Skip to main content
Search form
Search
Subscribe to newsletter +
European Association of Hospital Pharmacists
Menu
Main menu
Home
About Us
Who we are
Board
Staff
Students
Transparency
Contact Information
Call for Expressions of Interest
Members
Associate membership
News
Press Releases
EAHP Newsletters
EAHP in the news
Multimedia Gallery
Events
Calendar
Academy
Synergy Masterclass
EAHP BOOST
Congresses
General Assemblies
Accreditations
EAHP Synergy Certification Courses
Open Learning
Get Involved
Sponsors and partners
HP Practice
EAHP COVID-19 Resource Centre
European Statements of Hospital Pharmacy
What hospital pharmacists do
EAHP-ESCP Oath to Society
FIP global statements
National legislation on hospital pharmacy
Good Practice Initiatives
Common training framework
Environmental Sustainability
European Council for Pharmacy Education Accreditation
Investigation of the hospital pharmacy profession in Europe
Hospital Pharmacy Day
SIGs
Controlled Substances Management
Special Interest Group on Investigation of medication errors and efficiency in oncology
Automated Medication Management
Working Towards Eliminating Avoidable Harm
Hazardous Medicinal Products
Hospital Pharmacist’s Preparedness for in-vivo gene therapy medicinal products
Investigation of Medication Errors in Intensive Care Units
Use of Prefilled Syringes in Intensive Care Units and Operating Theaters
Policy
Resources
Consultations
Position Papers
Get involved and keep up to date
Access to Medicines
Ageing society
Infectious Diseases and AMR
ATMPs
Bar coding medicines to the single unit
Biosimilar medicines
Clinical trials
Digital Health
EMA - EAHP collaboration
European List of Emergency Medicines
Falsified Medicines
Hazardous Medicinal Products
Hospital Pharmacy Specialisation
Medical device regulation
Medicines shortages
Patient safety
Pharmaceuticals in the environment
Pharmacy preparations and compounding
Procurement
Public spending austerity
SmPC
Vaccination
Workforce
Statements
GPIs
Publications
2019 EP Election Manifesto
General information
EAHP Annual report
European Journals of Hospital Pharmacy
EAHP Surveys of HP practice
EAHP History Book
Practical Pharmaceutics
Congress presentation webcasts
2024 European Parliament Election Manifesto
Member Center
You are here
Home
Patient Safety and Risk Management
PS-102
CAN THE PATIENT BRING MEDICINE TO THE HOSPITAL? - THE USE AND RISK OF BROUGHT IN MEDICINES
PS-101
RISK MANAGEMENT OF HBV REACTIVATION IN HAEMATOLOGICAL PATIENTS TREATED WITH RITUXIMAB
PS-100
VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS FOR HOSPITALIZED MEDICAL PATIENTS (HMP) WITH LOW MOLECULAR WEIGHT HEPARIN (LMWH)
PS-099
DRUG-DRUG INTERACTIONS IN FLUOROPYRIMIDINES-BASED REGIMENS USED IN COLORECTAL CANCER TREATMENT
PS-098
ROLE OF THE PHARMACIST IN THE IMPLEMENTATION OF A COMPREHENSIVE SAFETY PROGRAM
PS-097
ADMISSIONS CAUSED BY IATROGENIC DISEASE IN A REFERENCE HOSPITAL
PS-096
DENOSUMAB-INDUCED HYPOCALCEMIA IN PATIENTS WITH METASTATIC BONE DISEASE
PS-095
DRUG INTERACTIONS BETWEEN IMATINIB AND THE USUAL HOME TREATMENT
PS-094
BISPHOSPHONATE TREATMENT AND ATYPICAL FRACTURES
PS-093
PHARMACEUTICAL INTERVENTION TO PREVENT METFORMIN-ASSOCIATED LACTIC ACIDOSIS IN DIABETICS ADMITTED WITH KIDNEY FAILURE
PS-092
EVALUATION OF PATIENT SAFETY CULTURE AMONG HEALTHCARE PROFESSIONALS IN A PHARMACY DEPARTMENT
PS-091
BENEFITS OF MEDICINES RECONCILIATION IN AN EMERGENCY UNIT
PS-090
RESULTS OF A MEDICINES RECONCILIATION PROGRAM IN COMPLEX CHRONIC PATIENTS AT HOSPITAL DISCHARGE
PS-089
IMPLANTATION OF A SAFETY STRATEGY FOR DRUG STORAGE IN A PHARMACY SERVICE
PS-087
MEDICINES RECONCILIATION AT HOSPITAL DISCHARGE
Pages
« first
‹ previous
…
6
7
8
9
10
11
12
13
14
…
next ›
last »
Follow Us